Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1991
03/07/1991WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells
03/07/1991WO1991002804A1 Recombinant adenovirus sequence expressing rhabdovirus antigen and use as a vaccine
03/07/1991WO1991002756A1 Prohormone cleavage site blocking antibody
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
03/07/1991WO1991002748A1 Rubella e1 peptides
03/07/1991WO1991002544A1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a protein which is distinct from this virus
03/07/1991WO1991002543A1 Stabilized vaccine compositions
03/07/1991WO1991002541A1 Detection and treatment of infections with immunoconjugates
03/07/1991WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof
03/07/1991CA2065023A1 Stabilized vaccine compositions
03/07/1991CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof
03/07/1991CA2039141A1 Composition resulting from the combination of the glycoprotein coat epitoque b of a type iv retrovirus and of an epitope t from a separate protein coded with this retrovirus, and their application for the production of protectors c antibodies for aids
03/06/1991EP0415801A1 Monoclonal antibodies against activated microglial cells
03/06/1991EP0415794A1 Complexes having adjuvant activity
03/06/1991EP0415557A2 Separation of anti-metal chelate antibodies
03/06/1991EP0414757A1 An agent for desensitizing man and/or animals against an allergen
03/06/1991EP0414728A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO
03/06/1991EP0162054B1 Production of cdna representing hepatitis a viral sequences
03/05/1991US4997915 Purification of pertussis toxins
03/05/1991US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy
03/05/1991US4997767 Genetic engineering
03/05/1991US4997647 Polypeptide
03/05/1991CA1280986C Thymidine kinase deletion mutants of bovine herpesvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
03/05/1991CA1280972C Complex immunogen containing synthetic peptides
03/03/1991CA2024167A1 Hyposensitization agent
03/02/1991WO1991003492A1 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES
03/02/1991WO1991003256A1 Adjuvant complexes
03/02/1991CA2065278A1 Modified human anti-rh(d) antibodies
03/02/1991CA2064911A1 Adjuvant complexes
03/01/1991WO1991003494A1 Cationized carriers for immunogen production
03/01/1991CA2067124A1 Cationized carriers for immunogen production
02/1991
02/27/1991EP0414475A1 Methods for culturing HCV in eukaryotic cells
02/27/1991EP0414374A2 Novel antigens and methods for their preparation
02/27/1991EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated
02/27/1991EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413738A1 Vectors encoding hcmv glycoprotein and expression products
02/27/1991EP0413709A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
02/27/1991EP0413687A1 Sequential improved method for treatment of human blood-clotting factor products
02/27/1991CN1049523A Escherichia coli vaccine
02/27/1991CN1049519A Pseudorabies virus not occurring in nature and vaccines containing same
02/26/1991WO1991002820A1 Methods for culturing hcv in eukaryotic cells
02/26/1991WO1991002799A1 Fusion proteins
02/26/1991WO1991002542A1 Treatment of chronic inflammatory conditions
02/26/1991US4996299 Method for preparing pertussis toxin toxoid using HcHo and amino acids
02/26/1991US4996297 contraceptives for non-rodent mammals
02/26/1991US4996194 Activated lymphocytes having increased antigenic activity; for vaccines
02/26/1991US4996152 Avian herpesvirus amplicon as a eucaryotic expression vector
02/26/1991CA1280693C Purification of pertussis antigens
02/26/1991CA1280690C Method for screening and treatment
02/24/1991WO1991002977A1 Wound healing preparations containing heparanase
02/24/1991WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
02/24/1991CA2065744A1 Wound healing preparations containing heparanase
02/24/1991CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
02/23/1991WO1991002752A1 Bovine coronavirus polypeptides and vaccines
02/21/1991WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
02/21/1991WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
02/21/1991WO1991002062A2 C-erbb-2 external domain: gp75
02/21/1991WO1991002061A1 Recombinant human thyroid peroxidase
02/21/1991WO1991002058A1 Production of vascular endothelial cell growth factor
02/21/1991WO1991002054A1 Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
02/21/1991WO1991002053A1 Low virulence laryngotracheitis (ilt) virus for vaccinating birds
02/21/1991WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides
02/21/1991WO1991002004A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII
02/21/1991WO1991001755A1 Pharmaceutical product for the treatment of sepsis
02/21/1991WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
02/21/1991WO1991001743A1 Stabilized protein or peptide conjugates
02/21/1991WO1991001727A2 Method of detection and treatment of malignant and non-malignant lesions by photochemotherapy
02/21/1991WO1991001639A1 Methods and compositions for ameliorating the symptoms of sepsis
02/21/1991WO1990015618A3 Srif-related peptides and uses thereof
02/21/1991WO1990011782A3 Immunoconjugates and prodrugs and their use in association for drug delivery
02/21/1991CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
02/20/1991EP0413637A1 Attenuated live hepatitis A vaccine (H2 Strain) and its method of preparation
02/20/1991EP0413622A1 Albumin derivatives with therapeutic functions
02/20/1991EP0413477A1 Monoclonal Antibody
02/20/1991EP0413383A1 Mutants of human interleukin-3
02/20/1991EP0413378A1 Escherichia coli vaccine
02/20/1991EP0413188A2 Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation
02/20/1991EP0413187A1 Method for producing an unmodified intravenous IgM- and/or IgA containing immunoglobulin preparation
02/20/1991EP0412970A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
02/19/1991WO1991002755A1 Fibulin
02/19/1991WO1991002546A1 A reagent for the detection of fibrinolytic activity
02/19/1991US4994560 Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
02/19/1991US4994554 Probursin
02/19/1991US4994438 For retention of coagulation activity in antihemophilic factor; deactivation of microorganisms
02/19/1991CA2065147A1 Reagent for the detection of fibrinolytic activity
02/19/1991CA2064818A1 Fibulin
02/19/1991CA2023521A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
02/19/1991CA1280365C Radionuclide antibody coupling
02/19/1991CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii
02/18/1991WO1991002795A1 Mutant pseudorabies virus, and vaccines containing the same
02/18/1991CA2065002A1 Mutant pseudorabies virus, and vaccines containing the same
02/17/1991CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof
02/16/1991CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof
02/16/1991CA2000634A1 Vaccine against avian encephalomyelitis
02/14/1991DE3926206A1 Whooping cough vaccine prodn. - using itaconic acid to inactivate microorganisms
02/13/1991EP0412766A1 Peptide fragments of HIV
02/13/1991EP0412762A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins
02/13/1991EP0412700A1 Method for isolating fetal cytotrophoblast cells
1 ... 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 ... 1823